| Pfizer-Statement liest sich eher positiv |  |
>Läuft. Ob von der Produktionsausweitung Europa profitiert, oder die zusätzlichen Dosen nach Israel/USA gehen, ist nicht überliefert.
Pfizer said it had to make modifications to the process and facility that will require additional regulatory approvals, Reuters reported. “Although this will temporarily impact shipments in late January to early February, it will provide a significant increase in doses available for patients in late February and March,” it said in a statement. (The Guardian)
Greets
Rocco